๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Plasma NO-binding activity in patients with hematological malignancies: Suppressive effect of glucocorticoids

โœ Scribed by V. I. Petukhov; I. Ya. Kalvinsh; I. K. Shestakova; I. A. Domracheva; I. Ya. Kanepe; R. G. Stibel; M. A. Romanova; A. P. Skesters

Publisher
Springer US
Year
2006
Tongue
English
Weight
345 KB
Volume
142
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pulmonary side effects of interferon-ฮฑ t
Pulmonary side effects of interferon-ฮฑ therapy in patients with hematological malignancies
โœ Patrik Anderson; Martin Hรถglund; Stig Rรถdjer ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB ๐Ÿ‘ 1 views

## Abstract Several side effects of interferonโ€ฮฑโ€2b (IFNโ€ฮฑ) therapy have been described. Pulmonary side effects have seldom been reported. The four patients we describe all developed respiratory disorders while being treated with IFNโ€ฮฑ for hematological malignancies. We point out the similarities a

Plasma concentration of itraconazole in
Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole
โœ Yoshinobu Kanda; Masahiro Kami; Tomohiro Matsuyama; Kinuko Mitani; Shigeru Chiba ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 2 views

Fungal infection is a serious complication in immunocompromised patients, especially those with neutropenia. Itraconazole (ITZ) is expected to be an effective prophylactic agent for fungal infection because it has more activity against Aspergillus species than fluconazole and it is less toxic than a